New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 14, 2024

Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can

February 15, 2025

Mass General Brigham Launches Healthcare AI Challenge

What You Should Know: – Forward, a technology-driven preventive primary care provider, has announced the immediate closure of all its locations and the shutdown of

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.